FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump

FBR Capital Markets initiated coverage on shares of TherapeuticsMD TXMD with an “outperform” rating. The target price for TherapeuticsMD is set to $34. TherapeuticsMD shares have jumped 54.10% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period. TherapeuticsMD's shares jumped 32.93% to $5.49 in pre-market trading.